Developing a vaccine to protect against hepatitis C virus
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
['FUNDING_OTHER'] · STANFORD UNIVERSITY · NIH-11074564
This study is working on a vaccine to help people who have been exposed to the hepatitis C virus by boosting their immune system to fight off the virus, similar to how some people naturally recover from it.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | STANFORD UNIVERSITY (nih funded) |
| Locations | 1 site (STANFORD, UNITED STATES) |
| Trial ID | NIH-11074564 on ClinicalTrials.gov |
What this research studies
This research aims to create a vaccine that can prevent disease progression in individuals exposed to the hepatitis C virus (HCV). It focuses on understanding how some patients naturally clear the virus and develop immunity, and seeks to replicate this immune response through vaccination. The approach involves inducing strong and lasting immune responses from both B and T cells, which are crucial for fighting off the virus. The project includes multiple components that work together to enhance the effectiveness of the vaccine.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of hepatitis C infection, including those with potential exposure to the virus.
Not a fit: Patients who are already infected with hepatitis C or those with advanced liver disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a vaccine that significantly reduces the risk of hepatitis C infection and its associated complications.
How similar studies have performed: Previous research has shown promise in developing vaccines for viral infections, but this specific approach to hepatitis C is novel and untested.
Where this research is happening
STANFORD, UNITED STATES
- STANFORD UNIVERSITY — STANFORD, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FOUNG, STEVEN — STANFORD UNIVERSITY
- Study coordinator: FOUNG, STEVEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.